Our mechanistic exploration of the synthetic lethality between EMP and ARID1A suggests that PI3K protein is notably activated in ARID1A-deficent cells where it binds to MAP4 and facilitates its phosphorylation, thereby increasing the sensitivity of ARID1A-deficient CRC cells to EMP. This evidence concerns the gene MAP4 and colorectal carcinoma.